Sign Up to like & get
recommendations!
0
Published in 2017 at "Interventional cardiology clinics"
DOI: 10.1016/j.iccl.2016.08.010
Abstract: There is significant interpatient variability in clopidogrel effectiveness, which is due in part to cytochrome P450 (CYP) 2C19 genotype. Approximately 30% of individuals carry CYP2C19 loss-of-function alleles, which have been consistently shown to reduce clopidogrel…
read more here.
Keywords:
genetic determinants;
cardiology;
clinical implications;
inhibitors clinical ... See more keywords